Beta
ACE inhibitors (e.g. lisinopril, enalapril, ramipril)
medication Under reviewACE inhibitors are a class of prescription medications that block angiotensin-converting enzyme, thereby reducing the formation of angiotensin II, a potent vasoconstrictor. By lowering angiotensin II levels, they relax blood vessels, reduce aldosterone secretion, decrease sodium and water retention, and lower blood pressure. Lisinopril, enalapril, and ramipril are three commonly used agents in this class. Beyond blood pressure control, ACE inhibitors improve hemodynamics by reducing afterload and favorably influencing cardiac remodeling. They increase cardiac output and reduce left ventricular mass, which helps prevent or slow the progression of heart failure in at-risk individuals. These drugs are widely used for hypertension, coronary artery disease, post–myocardial infarction management, and kidney protection in people with diabetes and chronic kidney disease. ACE inhibitors also have ancillary applications, such as migraine prophylaxis in selected patients and potential cognitive benefits in older adults with vascular risk factors. However, they are pharmacologic therapies rather than over‑the‑counter supplements, and their use in healthy individuals without clear indications is not standard practice due to the risk of adverse effects like cough, hyperkalemia, and rare but serious angioedema.
Research summary
In healthy or relatively healthy human populations with elevated cardiovascular risk but without established heart failure, large randomized trials have shown that ACE inhibitors, particularly ramipril, reduce major cardiovascular events including myocardial infarction, stroke, and cardiovascular death. These benefits are primarily mediated through blood pressure reduction, improved vascular function, and attenuation of adverse cardiac remodeling, and they underpin current guideline recommendations for ACE inhibitor use in hypertension and high‑risk cardiovascular prevention. Safety data from randomized trials and long‑term follow‑up indicate that ACE inhibitors are generally well tolerated but have characteristic adverse effect profiles, including dry cough, dizziness from blood pressure lowering, hyperkalemia, and rare angioedema. Migraine prophylaxis and cognitive benefits have been reported mainly in patients with hypertension or other vascular conditions rather than completely healthy volunteers. Overall, the research consensus supports ACE inhibitors as effective, disease‑modifying cardiovascular medications, not general wellness supplements, and their use should be individualized and medically supervised.
Reported Benefits
No reports yet
Be the first to report this effect and help the community.
Add Ace inhibitors (e.g. lisinopril, enalapril, ramipril) to your stack to report effects
Lisinopril and Enalapril in the Prophylactic Treatment of Migraine: A Randomized, Double-Blind, Crossover Trial
Stovner LJ, Schrader H, et al.
Migraine Prophylaxis With Lisinopril: A Randomized, Placebo-Controlled, Crossover Study
Schrader H, Stovner LJ, Helde G, Sand T, Bovim G
No reports yet
Be the first to report this effect and help the community.
Add Ace inhibitors (e.g. lisinopril, enalapril, ramipril) to your stack to report effects
Plasma renin activity predicts cardiovascular mortality in the Heart Outcomes Prevention Evaluation (HOPE) study.
Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G
Comparative Effects of Low and High Doses of the Angiotensin-Converting Enzyme Inhibitor Lisinopril on Mortality and Morbidity in Chronic Heart Failure
Pitt B, Poole-Wilson PA, Segal R, Martinez FA, et al.
No reports yet
Be the first to report this effect and help the community.
Add Ace inhibitors (e.g. lisinopril, enalapril, ramipril) to your stack to report effects
Plasma renin activity predicts cardiovascular mortality in the Heart Outcomes Prevention Evaluation (HOPE) study.
Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G
Comparative Effects of Low and High Doses of the Angiotensin-Converting Enzyme Inhibitor Lisinopril on Mortality and Morbidity in Chronic Heart Failure
Pitt B, Poole-Wilson PA, Segal R, Martinez FA, et al.
No reports yet
Be the first to report this effect and help the community.
Add Ace inhibitors (e.g. lisinopril, enalapril, ramipril) to your stack to report effects
Mortality and Morbidity Among Individuals With Hypertension Stratified by Initial Treatment Strategy
Jha AK, Chou E, Christian J, et al.
Plasma renin activity predicts cardiovascular mortality in the Heart Outcomes Prevention Evaluation (HOPE) study.
Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G
Reported Side Effects
No reports yet
Be the first to report this effect and help the community.
Add Ace inhibitors (e.g. lisinopril, enalapril, ramipril) to your stack to report effects
Mortality and Morbidity Among Individuals With Hypertension Stratified by Initial Treatment Strategy
Jha AK, Chou E, Christian J, et al.
No reports yet
Be the first to report this effect and help the community.
Add Ace inhibitors (e.g. lisinopril, enalapril, ramipril) to your stack to report effects
Mortality and Morbidity Among Individuals With Hypertension Stratified by Initial Treatment Strategy
Jha AK, Chou E, Christian J, et al.
No reports yet
Be the first to report this effect and help the community.
Add Ace inhibitors (e.g. lisinopril, enalapril, ramipril) to your stack to report effects
Mortality and Morbidity Among Individuals With Hypertension Stratified by Initial Treatment Strategy
Jha AK, Chou E, Christian J, et al.
Related health conditions
Research showing how this habit affects specific health conditions. Always consult healthcare professionals.
May Help With
Coronary artery disease or other cardiac conditions
Comparative Effects of Low and High Doses of the Angiotensin-Converting Enzyme Inhibitor Lisinopril on Mortality and Morbidity in Chronic Heart Failure
Pitt B, Poole-Wilson PA, Segal R, Martinez FA, et al.
Plasma renin activity predicts cardiovascular mortality in the Heart Outcomes Prevention Evaluation (HOPE) study.
Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G
Hypertension — elevated blood pressure requiring management
Mortality and Morbidity Among Individuals With Hypertension Stratified by Initial Treatment Strategy
Jha AK, Chou E, Christian J, et al.
Plasma renin activity predicts cardiovascular mortality in the Heart Outcomes Prevention Evaluation (HOPE) study.
Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G
Progressive loss of kidney function over time
Mortality and Morbidity Among Individuals With Hypertension Stratified by Initial Treatment Strategy
Jha AK, Chou E, Christian J, et al.
Recurrent severe headaches often with nausea and light sensitivity
Migraine Prophylaxis With Lisinopril: A Randomized, Placebo-Controlled, Crossover Study
Schrader H, Stovner LJ, Helde G, Sand T, Bovim G
Lisinopril and Enalapril in the Prophylactic Treatment of Migraine: A Randomized, Double-Blind, Crossover Trial
Stovner LJ, Schrader H, et al.
Research (5 studies)
Mortality and Morbidity Among Individuals With Hypertension Stratified by Initial Treatment Strategy
Jha AK, Chou E, Christian J, et al.
Lisinopril and Enalapril in the Prophylactic Treatment of Migraine: A Randomized, Double-Blind, Crossover Trial
Stovner LJ, Schrader H, et al.
Migraine Prophylaxis With Lisinopril: A Randomized, Placebo-Controlled, Crossover Study
Schrader H, Stovner LJ, Helde G, Sand T, Bovim G
Plasma renin activity predicts cardiovascular mortality in the Heart Outcomes Prevention Evaluation (HOPE) study.
Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G
Comparative Effects of Low and High Doses of the Angiotensin-Converting Enzyme Inhibitor Lisinopril on Mortality and Morbidity in Chronic Heart Failure
Pitt B, Poole-Wilson PA, Segal R, Martinez FA, et al.
Community updates
No updates yet for this supplement.
Be the first to share your experience!